Citigroup’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-7
| Closed | -$49 | – | 4857 |
|
2023
Q1 | $49 | Sell |
7
-45
| -87% | -$315 | ﹤0.01% | 4590 |
|
2022
Q4 | $309 | Buy |
52
+8
| +18% | +$48 | ﹤0.01% | 4761 |
|
2022
Q3 | $1K | Sell |
44
-132
| -75% | -$3K | ﹤0.01% | 4829 |
|
2022
Q2 | $3K | Sell |
176
-38
| -18% | -$648 | ﹤0.01% | 4994 |
|
2022
Q1 | $6K | Sell |
214
-700
| -77% | -$19.6K | ﹤0.01% | 4951 |
|
2021
Q4 | $39K | Buy |
914
+571
| +166% | +$24.4K | ﹤0.01% | 4420 |
|
2021
Q3 | $24K | Buy |
343
+149
| +77% | +$10.4K | ﹤0.01% | 4403 |
|
2021
Q2 | $22K | Sell |
194
-42
| -18% | -$4.76K | ﹤0.01% | 4573 |
|
2021
Q1 | $24K | Sell |
236
-353
| -60% | -$35.9K | ﹤0.01% | 4482 |
|
2020
Q4 | $28K | Buy |
589
+438
| +290% | +$20.8K | ﹤0.01% | 4445 |
|
2020
Q3 | $4K | Sell |
151
-140
| -48% | -$3.71K | ﹤0.01% | 4769 |
|
2020
Q2 | $11K | Sell |
291
-8
| -3% | -$302 | ﹤0.01% | 4600 |
|
2020
Q1 | $15K | Buy |
299
+81
| +37% | +$4.06K | ﹤0.01% | 4491 |
|
2019
Q4 | $10K | Buy |
218
+165
| +311% | +$7.57K | ﹤0.01% | 4713 |
|
2019
Q3 | $2K | Sell |
53
-266
| -83% | -$10K | ﹤0.01% | 4962 |
|
2019
Q2 | $16K | Sell |
319
-719
| -69% | -$36.1K | ﹤0.01% | 4641 |
|
2019
Q1 | $82K | Buy |
+1,038
| New | +$82K | ﹤0.01% | 3712 |
|
2018
Q2 | – | Sell |
-2
| Closed | – | – | 5045 |
|
2018
Q1 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 4979 |
|
2017
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4998 |
|
2017
Q3 | – | Sell |
-494
| Closed | -$51K | – | 4813 |
|
2017
Q2 | $51K | Buy |
+494
| New | +$51K | ﹤0.01% | 3577 |
|
2016
Q4 | – | Sell |
-2
| Closed | – | – | 4926 |
|
2016
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4959 |
|
2016
Q2 | – | Sell |
-138
| Closed | -$13K | – | 5162 |
|
2016
Q1 | $13K | Buy |
138
+106
| +331% | +$9.99K | ﹤0.01% | 4732 |
|
2015
Q4 | $4K | Buy |
+32
| New | +$4K | ﹤0.01% | 5025 |
|